WHO-HAEM5（第5版造血與淋巴組織腫瘤分類）是2022年由世界衛(wèi)生組織（WHO）發(fā)布的分類體系，旨在為全球血液系統(tǒng)腫瘤的診斷提供標準化框架?。此次版本命名保留傳統(tǒng)以維持臨床連續(xù)性，同時由血液病理學家、遺傳學家等MICM多學科共同參與制定，整合分子遺傳學進展，確保分類的臨床實用性?。

• Clonal Haematopoiesis (CH)，克隆性造血

• Age-related Clonal Haematopoiesis (ARCH)，年齡相關的克隆性造血

• Clonal haematopoiesis of indeterminate potential (CHIP)，不確定潛能的克隆性造血

• Clonal cytopenia of undetermined significance (CCUS)，意義未明克隆性血細胞減少

• Idiopathic cytopenias of unknown significance (ICUS)，意義未明特發(fā)性血細胞減少

• Chronic myeloid leukaemia (CML)，慢性髓系白血病

• Chronic neutrophilic leukaemia (CNL)，慢性中性粒細胞白血病

• Chronic eosinophilic leukaemia (CEL)，慢性嗜酸粒細胞白血病

• Polycythaemia vera (PV) ，真性紅細胞增多癥

• Essential thrombocythaemia (ET)，原發(fā)性血小板增多癥

• Primary myelofibrosis (PMF)，原發(fā)性骨髓纖維化

• Juvenile myelomonocytic leukaemia (JMML)，幼年型粒單核細胞白血病

• myeloproliferative neoplasm,NOS (MPN-NOS)，骨髓增生性腫瘤，非特指型

• Urticaria Pigmentosa/Maculopapular Cutaneous Mastocytosis (UP/MCPM)，色素性蕁麻疹/斑丘疹性皮膚肥大細胞增多癥

• Diffuse Cutaneous Mastocytosis (DCM)，彌漫性皮膚肥大細胞增多癥

• Bone Marrow Mastocytosis (BMM)， 骨髓肥大細胞增多癥

• Indolent Systemic Mastocytosis (ISM)，惰性系統(tǒng)性肥大細胞增多癥

• Smouldering Systemic Mastocytosis (SSM)，冒煙型系統(tǒng)性肥大細胞增多癥

• Aggressive Systemic Mastocytosis (ASM)，侵襲性系統(tǒng)性肥大細胞增多癥

• SM with an Associated Haematologic Neoplasm (SM-AHN)，SM伴有相關的血液腫瘤

• Mast cell leukaemia (MCL)，肥大細胞白血病

• Myelodysplastic neoplasm with low blasts and 5q deletion (MDS-5q)，MDS伴低原始細胞和孤立5q缺失

• Myelodysplastic neoplasm with low blasts and SF3B1 mutation (MDS-SF3B1)，MDS伴低原始細胞和SF3B1突變

• Myelodysplastic neoplasm with biallelic TP53 inactivation (MDS-bi TP53)，MDS伴TP53雙等位基因失活突變

• Myelodysplastic neoplasm with low blasts (MDS-LB)，低原始細胞MDS

• Myelodysplastic neoplasm, hypoplastic (MDS-h)， 低增生MDS

• Myelodysplastic neoplasm with increased blasts (MDS-IB)，MDS伴原始細胞增多

• Childhood myelodysplastic neoplasm with low blasts，低原始細胞兒童MDS

• Childhood myelodysplastic neoplasm with increased blasts，兒童MDS伴原始細胞增多

• Chronic myelomonocytic leukaemia (CMML)，慢性粒單核細胞白血病

• Myelodysplastic/myeloproliferative neoplasm with neutrophilia (MDS/MPN-N)，骨髓增生異常/骨髓增生性腫瘤伴中性粒細胞增多

• Myelodysplastic/myeloproliferative neoplasm with SF3B1 mutation and thrombocytosis (MDS/MPNSF3B1-T)，伴有SF3B1突變和血小板增多的骨髓增生異常/骨髓增生性腫瘤

• Myelodysplastic/myeloproliferative neoplasm, NOS (MDS/MPN-NOS)，骨髓增生異常綜合征/骨髓增生性腫瘤，非特指型

• Acute promyelocytic leukaemia with PML::RARA fusion，APL伴PML::RARA融合

• Acute myeloid leukaemia with RUNX1::RUNX1T1 fusion，AML伴RUNX1::RUNX1T1融合

• Acute myeloid leukaemia with CBFB::MYH11 fusion，AML伴CBFB::MYH11融合

• Acute myeloid leukaemia with DEK::NUP214 fusion，AML伴DEK::NUP214融合

• Acute myeloid leukaemia with RBM15::MRTFA fusion，AML伴RBM15::MRTFA融合

• Acute myeloid leukaemia with BCR::ABL1 fusion，AML伴BCR::ABL1融合

• Acute myeloid leukaemia with KMT2A rearrangement，AML伴KMT2A重排

• Acute myeloid leukaemia with MECOM rearrangement，AML伴MECOM重排

• Acute myeloid leukaemia with NUP98 rearrangement，AML伴NUP98重排

• Acute myeloid leukaemia with NPM1 mutation，AML伴NPM1突變

• Acute myeloid leukaemia with CEBPA mutation，AML伴CEBPA突變

• Acute myeloid leukaemia, myelodysplasia-related (AML-MR)，AML骨髓增生異常相關

• Acute myeloid leukaemia with other defined genetic alterations，AML伴其他遺傳學改變定義類型

• Acute myeloid leukaemia with minimal differentiation，AML伴微分化

• Acute myeloid leukaemia without maturation，AML不伴成熟型

• Acute myeloid leukaemia with maturation，AML伴成熟型

• Acute basophilic leukaemia (ABL)，急性嗜堿性粒細胞白血病

• Acute myelomonocytic leukaemia，急性粒單核細胞白血病

• Acute monocytic leukaemia，急性單核細胞白血病

• Acute erythroid leukaemia (AEL)，急性紅系白血病

• Acute megakaryoblastic leukaemia (AMKL)，急性原始巨核細胞白血病

• Myeloid neoplasm post cytotoxic therapy (MN-pCT)，細胞毒治療后髓系腫瘤

• Myeloid neoplasms associated with germline predisposition，胚系易感性髓系腫瘤

• Myeloid proliferations associated with Down syndrome，唐綜合征相關的骨髓增生

• Myeloid/lymphoid neoplasm with PDGFRA rearrangement，髓系/淋巴樣腫瘤伴有PDGFRA重排

• Myeloid/lymphoid neoplasm with PDGFRB rearrangement，髓系/淋巴樣腫瘤伴有PDGFRB重排

• Myeloid/lymphoid neoplasm with FGFR1 rearrangement，髓系/淋巴樣腫瘤伴有FGFR1重排

• Myeloid/lymphoid neoplasm with JAK2 rearrangement，髓系/淋巴樣腫瘤伴有JAK2重排

• Myeloid/lymphoid neoplasm with FLT3 rearrangement，髓系/淋巴樣腫瘤伴有FLT3重排

• Myeloid/lymphoid neoplasm with ETV6::ABL1 fusion，髓系/淋巴樣腫瘤伴有ETV6:ABL1融

• Myeloid/lymphoid neoplasms with other tyrosine kinase fusion genes，髓系/淋巴樣腫瘤伴其他酪氨酸激酶融合基因

• Mixed-phenotype acute leukaemia with BCR::ABL1 fusion，混合表型急性白血病伴BCR::ABL1融合

• Mixed-phenotype acute leukaemia with KMT2A rearrangement，混合表型急性白血病伴KMT2A重排

• Acute leukaemia of ambiguous lineage with other defined genetic alterations，不明系列急性白血病伴其他明確遺傳學改變

• Mixed-phenotype acute leukaemia, B/myeloid，混合表型急性白血病，B/髓

• Mixed-phenotype acute leukaemia, T/myeloid，混合表型急性白血病，T/髓

• Mixed-phenotype acute leukaemia, rare types，混合表型急性白血病，罕見類型

• Acute leukaemia of ambiguous lineage, NOS，不明系列急性白血病，非特指型

• Acute undifferentiated leukaemia，急性未分化白血病

• Mature plasmacytoid dendritic cell proliferation associated with myeloid neoplasm (MPDCP)，髓細胞腫瘤相關性成熟漿細胞樣樹突狀細胞增生

• Blastic plasmacytoid dendritic cell neoplasm (BPDCN)，母細胞性漿細胞樣樹突細胞瘤

• Langerhans cell histiocytosis (LCH)，朗格漢斯細胞組織細胞增生癥

• Langerhans cell sarcoma (LCS)，朗格漢斯細胞肉瘤

• Indeterminate dendritic cell tumour (IDCT) ，未確定樹突細胞腫瘤

• Interdigitating dendritic cell sarcoma (IDCS)，交指樹突狀細胞肉瘤

• Juvenile xanthogranuloma (DJXG), 幼年性黃色肉芽腫

• Erdheim-Chester disease(ECD)，Erdheim-Chester病

• Rosai-Dorfman Disease (RDD)，Rosai-Dorfman病

• ALK-positive histiocytosis (APH), ALK陽性組織細胞增生癥

• Histiocytic sarcoma (HS)，組織細胞肉瘤

• Follicular dendritic cell sarcoma (FDCS)，濾泡樹突細胞肉瘤

• EBV-positive inflammatory follicular dendritic cell sarcoma，EBV陽性炎性濾泡樹突狀細胞肉瘤

• Fibroblastic reticular cell tumour (FRCT)，纖維母細胞性網(wǎng)狀細胞腫瘤

• Intranodal palisaded myofibroblastoma，結內柵欄狀肌纖維母細胞瘤

• Splenic vascular-stromal tumours，脾血管間質瘤

• Littoral cell angioma，脾竇岸細胞血管瘤

• Splenic hamartoma，脾錯構瘤

• Sclerosing angiomatoid nodular transformation (SANT) of spleen，脾硬化性血管瘤樣結節(jié)性轉化

下一期內容為淋系造血腫瘤的中英文對照

敬請關注！